Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice

Biochemical Pharmacology

Volumn 84, Issue 11, 2012, Pages 1459-1469

  Bento, Allisson Freire ^a   Leite, Daniela Ferraz Pereira ^a   Marcon, Rodrigo ^a   Claudino, Rafaela Franco ^a   Dutra, Rafael Cypriano ^a   Cola, Maíra ^a   Martini, Alessandra Cadete ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Cell influx; Chronic inflammation; Colitis; Dextran sodium sulfate; Inflammatory mediators

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; KERATINOCYTE DERIVED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHEMICAL ANALYSIS; COLITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ACTIVITY; INTESTINE MUCOSA; KINETICS; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DEXTRAN SULFATE; GASTROENTERITIS; MALE; MICE; MICE, INBRED BALB C; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84868462865     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.09.007     Document Type: Article

References (47)

1. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
2. J.K. Triantafillidis, E. Merikas, and F. Georgopoulos Current and emerging drugs for the treatment of inflammatory bowel disease Drug Des Devel Ther 5 2011 185 210
3. D.C. Baumgart, and S.R. Carding Inflammatory bowel disease: cause and immunobiology Lancet 369 2007 1627 1640
4. S. Wirtz, C. Neufert, B. Weigmann, and M.F. Neurath Chemically induced mouse models of intestinal inflammation Nat Protoc 2 2007 541 546
5. A. Schirbel, and C. Fiocchi Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy J Dig Dis 11 2010 266 276
6. W. Strober, I. Fuss, and P. Mannon The fundamental basis of inflammatory bowel disease J Clin Invest 117 2007 514 521
7. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
8. T. Tanaka, H. Kohno, R. Suzuki, Y. Yamada, S. Sugie, and H. Mori A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate Cancer Sci 94 2003 965 973
9. J.E. Ghia, P. Blennerhassett, and S.M. Collins Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression J Clin Invest 118 2008 2209 2218
10. H.S. Cooper, S.N. Murthy, R.S. Shah, and D.J. Sedergran Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 1993 238 249
11. A.F. Bento, D.F. Leite, R.F. Claudino, D.B. Hara, P.C. Leal, and J.B. Calixto The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice J Leukoc Biol 84 2008 1213 1221
12. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
13. J.L. Wallace COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation ScientificWorldJournal 6 2006 577 588
14. A.F. Bento, R.F. Claudino, R.C. Dutra, R. Marcon, and J.B. Calixto Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice J Immunol 187 2011 1957 1969
15. S. Danese, S. Semeraro, M. Marini, I. Roberto, A. Armuzzi, and A. Papa Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation Dig Liver Dis 37 2005 811 818
16. E.J. Albert, J. Duplisea, W. Dawicki, I.D. Haidl, and J.S. Marshall Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells Am J Pathol 178 2011 150 160
17. J. Wang, and A. Slungaard Role of eosinophil peroxidase in host defense and disease pathology Arch Biochem Biophys 445 2006 256 260
18. S.A. Woodruff, J.C. Masterson, S. Fillon, Z.D. Robinson, and G.T. Furuta Role of eosinophils in inflammatory bowel and gastrointestinal diseases J Pediatr Gastroenterol Nutr 52 2011 650 661
19. M. Miyamoto, O. Prause, M. Sjostrand, M. Laan, J. Lotvall, and L.A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways J Immunol 170 2003 4665 4672
20. S.E. Moreno, J.C. Alves-Filho, T.M. Alfaya, J.S. da Silva, S.H. Ferreira, and F.Y. Liew IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture J Immunol 177 2006 3218 3224
21. S.J. Smart, and T.B. Casale TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent Am J Physiol 266 1994 L238 L245
22. L. Li, L. Huang, A.L. Vergis, H. Ye, A. Bajwa, and V. Narayan IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury J Clin Invest 120 2010 331 342
23. W. Strober, and I.J. Fuss Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases Gastroenterology 140 2011 1756 1767
24. P.J. Mannon, I.J. Fuss, L. Mayer, C.O. Elson, W.J. Sandborn, and D. Present Anti-interleukin-12 antibody for active Crohn's disease N Engl J Med 351 2004 2069 2079
25. R. Ito, M. Kita, M. Shin-Ya, T. Kishida, A. Urano, and R. Takada Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice Biochem Biophys Res Commun 377 2008 12 16
26. N. Lugering, T. Kucharzik, H. Stein, G. Winde, A. Lugering, and A. Hasilik IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease Dig Dis Sci 43 1998 706 714
27. T. Kucharzik, N. Lugering, H.G. Pauels, W. Domschke, and R. Stoll IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells Clin Exp Immunol 111 1998 152 157
28. M.N. Ajuebor, A. Singh, and J.L. Wallace Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis Am J Physiol Gastrointest Liver Physiol 279 2000 G238 G244
29. S.R. Zamuner, N. Warrier, A.G. Buret, W.K. MacNaughton, and J.L. Wallace Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction Gut 52 2003 1714 1720
30. K. Shibata, H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production J Immunol 178 2007 4466 4472
31. N. Takahashi, I. Vanlaere, R. de Rycke, A. Cauwels, L.A. Joosten, and E. Lubberts IL-17 produced by Paneth cells drives TNF-induced shock J Exp Med 205 2008 1755 1761
32. J.T. Kaifi, E. Diaconu, and E. Pearlman Distinct roles for PECAM-1, ICAM-1, and VCAM-1 in recruitment of neutrophils and eosinophils to the cornea in ocular onchocerciasis (river blindness) J Immunol 166 2001 6795 6801
33. D.M. Briscoe, R.S. Cotran, and J.S. Pober Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration J Immunol 149 1992 2954 2960
34. D.E. Staunton, M.L. Dustin, and T.A. Springer Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1 Nature 339 1989 61 64
35. J.F. McHale, O.A. Harari, D. Marshall, and Haskard D.O.T.N.F-alpha IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice J Immunol 163 1999 3993 4000
36. D.M. McCafferty, K.J. Rioux, and J.L. Wallace Granulocyte infiltration in experimental colitis in the rat is interleukin-1 dependent and leukotriene independent Eicosanoids 5 1992 121 125
37. M.A. Hoeve, N.D. Savage, T. de Boer, D.M. Langenberg, R. de Waal Malefyt, and T.H. Ottenhoff Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells Eur J Immunol 36 2006 661 670
38. A. Ogawa, A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice Clin Immunol 110 2004 55 62
39. K.S. Voo, Y.H. Wang, F.R. Santori, C. Boggiano, Y.H. Wang, and K. Arima Identification of IL-17-producing FOXP3+ regulatory T cells in humans Proc Natl Acad Sci U S A 106 2009 4793 4798
40. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, and R. Yang Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc Natl Acad Sci U S A 107 2010 1660 1665
41. S. Krishnamoorthy, A. Recchiuti, N. Chiang, G. Fredman, and C.N. Serhan Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs Am J Pathol 180 2012 2018 2027
42. K. Gronert, A. Gewirtz, J.L. Madara, and C.N. Serhan Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release J Exp Med 187 1998 1285 1294
43. S. Sodin-Semrl, B. Taddeo, D. Tseng, J. Varga, and S. Fiore Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases J Immunol 164 2000 2660 2666
44. S. Schreiber, T. Heinig, H.G. Thiele, and A. Raedler Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease Gastroenterology 108 1995 1434 1444
45. B.B. Ganesh, P. Bhattacharya, A. Gopisetty, J. Sheng, C. Vasu, and B.S. Prabhakar IL-1beta promotes TGF-beta1 and IL-2 dependent Foxp3 expression in regulatory T cells PLoS ONE 6 2011 e21949
46. S. Ghosh, and M.S. Hayden New regulators of NF-kappaB in inflammation Nat Rev Immunol 8 2008 837 848
47. C. Scheidereit IkappaB kinase complexes: gateways to NF-kappaB activation and transcription Oncogene 25 2006 6685 6705